Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced ...

'We are pleased to welcome Chris as we enter the next phase of our growth,' said Alignable CEO & Co-Founder Eric Groves. 'His expertise in scaling companies and his strategic vision will be invaluable ...

Broadcast intercom systems play a crucial role in coordinating complex productions and ensuring clear communication ... Read ...

Tech français consacré aux nouvelles technologies (internet, logiciel, matériel, mobilité, entreprise) et au jeu vidéo PC et consoles.

Tech français consacré aux nouvelles technologies (internet, logiciel, matériel, mobilité, entreprise) et au jeu vidéo PC et consoles.

We look forward to presenting our latest intercom solutions at NAB NY 2024,” said Gary Rosen, Vice President of Global Sales ...

Pliant Technologies, a leading provider of professional wireless intercom solutions, has announced that it will be showing a ...

Pliant Technologies, a provider of professional wireless intercom solutions, will feature a range of its latest innovations, including the … The post appeared first on TV News Check. The post NAB Show ...

Pliant Technologies will reveal its new PHS-IEHU Miniature In-ear Headset, among several enhancements to its range of ...

The exhibition includes decomposing sound sculptures, audio-video installations, specialized listening devices, and the use of responsive technologies. The artists in the exhibition create ...

Piper Sandler has reaffirmed its Overweight rating on shares of Pliant Therapeutics (NASDAQ: PLRX), maintaining a $40.00 price target. The endorsement follows a recent announcement from Boehringer ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Pliant Therapeutics (PLRX – Research Report) today and set a price target of $40.00. The company’s shares closed yesterday at ...